Clinical trial
Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
NCT00578929 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
- Lead sponsor
- Alcon Research
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2007
- Completion date
- Not reported
- Enrollment
- 2,388 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
seasonal allergic rhinitis